| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 794.487 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 547.709 | 92 |
| GSM780709 | Untreated after 4 days (C3_1) | 480.905 | 91 |
| GSM780719 | Untreated after 4 days (C1_2) | 753.648 | 94 |
| GSM780720 | Untreated after 4 days (C2_2) | 609.563 | 93 |
| GSM780721 | Untreated after 4 days (C3_2) | 481.148 | 91 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 542.307 | 92 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 730.334 | 94 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 765.981 | 94 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 568.127 | 92 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 740.595 | 94 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 836.907 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 666.781 | 93 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 536.283 | 92 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 620.144 | 93 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 690.903 | 94 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 618.569 | 93 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 641.095 | 93 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 791.077 | 94 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 685.092 | 94 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 694.221 | 94 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 788.779 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 638.227 | 93 |